About ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide
ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide (PubChem CID 142552025) has the molecular formula C36H52N6O4
and a molecular weight of 632.85 g/mol. Its IUPAC name is ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide.
Molecular Properties
| Compound Name | ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide |
| PubChem CID | 142552025 |
| Molecular Formula | C36H52N6O4 |
| Molecular Weight | 632.85 g/mol |
| Exact Mass | 632.41 |
| IUPAC Name | ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide |
| SMILES | CC.CC(C)C(CC(=O)N1CCC(O)(Cn2cnc3cc(NC(=O)CCN4CCN(C)CC4)ccc3c2=O)CC1)c1ccccc1 |
| InChI | InChI=1S/C34H46N6O4.C2H6/c1-25(2)29(26-7-5-4-6-8-26)22-32(42)39-15-12-34(44,13-16-39)23-40-24-35-30-21-27(9-10-28(30)33(40)43)36-31(41)11-14-38-19-17-37(3)18-20-38;1-2/h4-10,21,24-25,29,44H,11-20,22-23H2,1-3H3,(H,36,41);1-2H3 |
| InChIKey | WRCCVNZCYCWFDP-UHFFFAOYSA-N |
| XLogP | 4.18 |
| TPSA | 111.01 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 632.85 |
| LogP ≤ 5 | 4.18 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide?
The IUPAC name of ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide (CID 142552025) is ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide.
What is the SMILES notation for ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide?
The canonical SMILES for ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide is CC.CC(C)C(CC(=O)N1CCC(O)(Cn2cnc3cc(NC(=O)CCN4CCN(C)CC4)ccc3c2=O)CC1)c1ccccc1.
What is the InChIKey of ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide?
The InChIKey is WRCCVNZCYCWFDP-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H46N6O4.C2H6/c1-25(2)29(26-7-5-4-6-8-26)22-32(42)39-15-12-34(44,13-16-39)23-40-24-35-30-21-27(9-10-28(30)33(40)43)36-31(41)11-14-38-19-17-37(3)18-20-38;1-2/h4-10,21,24-25,29,44H,11-20,22-23H2,1-3H3,(H,36,41);1-2H3.
What are the key properties of ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide?
ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide has a molecular weight of 632.85 g/mol, XLogP of 4.18, 10 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for ethane;N-[3-[[4-hydroxy-1-(4-methyl-3-phenylpentanoyl)piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide is sourced from PubChem (CID 142552025), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).